Advanced Life Sciences Holdings, Inc. (OTCMKTS:ADLS) has a mean recommendation (this week): $3.0, according to Yahoo finance. Advanced Life Sciences Holdings, Inc. (OTCMKTS:ADLS) shares after opening at $0.06 moved to $0.06 on last trade day and at the end of the day closed at $0.0449.
On April 14, 2014, the registrant issued a press release announcing ERBA Diagnostics Inc. (NYSEMKT:ERB) financial results for the year ended December 31, 2013. ERBA Diagnostics Inc. (NYSEMKT:ERB) shares fell -7.65% in last trading session and ended the day on $1.69. ERB return on equity ratio is recorded as -6.20% and its return on assets is -4.00%. ERBA Diagnostics Inc. (NYSEMKT:ERB) yearly performance is 116.67%.
Net operating cash flow has remained constant at -$4.67 million with no significant change when compared to the same quarter last year. Even though there was no significant change, Idera Pharmaceuticals Inc. (NASDAQ:IDRA) cash flow growth rate is severely below the industry average. Idera Pharmaceuticals Inc. (NASDAQ:IDRA) shares moved down -5.78% in last trading session and was closed at $2.77, while trading in range of $2.74 – $3.09. Idera Pharmaceuticals Inc. (NASDAQ:IDRA) year to date (YTD) performance is -40.17%.
Inovio Pharmaceuticals (NYSE:INO) was downgraded by Zacks from an “outperform” rating to a “neutral” rating in a research report issued on Friday, StockRatingsNetwork.com reports. They currently have a $3.20 target price on the stock. Zacks‘s price target would indicate a potential upside of 26.98% from the company’s current price. Inovio Pharmaceuticals Inc. (NYSEMKT:INO) weekly performance is -16.00%. On last trading day company shares ended up $2.52. Inovio Pharmaceuticals Inc. (NYSEMKT:INO) distance from 50-day simple moving average (SMA50) is -21.44%. Analysts mean target price for the company is $4.60.
Leave a Reply